Bone Biologics (BBLG) vs CollPlant Biotechnologies (OPHI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CollPlant Biotechnologies is the larger company by market cap ($9.6 million vs $909,961), about 10.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBLG | OPHI |
|---|---|---|
| Share price | $0.2685 | $3.13 |
| Market cap | $909.96K | $9.63M |
| 1-day change | -2.40% | -2.49% |
| EPS (TTM) | $-1.02 | $-9.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $2.37M |
| Revenue growth (YoY) | — | +360.39% |
| Net income (latest FY) | $-3.11M | $-11.49M |
| Gross margin | — | 64.78% |
| Operating margin | — | -484.31% |
| Net margin | — | -484.56% |
| 52-week high | $2.39 | $22.50 |
| 52-week low | $0.261 | $2.64 |
| Distance from 52-week high | -88.77% | -86.09% |
| Analyst consensus | none | — |
| Avg. price target upside | +4443.76% | — |
| Average volume | 254.56K | 385.37K |
| Shares outstanding | 3.39M | 3.08M |
| Employees | 2 | — |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CollPlant Biotechnologies is about 10.6 times larger than Bone Biologics by market value ($9.63M vs $909.96K).
About Bone Biologics
BBLG stock →Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration.
Health Care · Industrial Specialties · 2 employees
BBLG vs OPHI FAQ
Which is bigger, Bone Biologics or CollPlant Biotechnologies?
CollPlant Biotechnologies (OPHI) is larger, with a market capitalization of $9.63M compared with $909.96K for Bone Biologics (BBLG).
Are Bone Biologics and CollPlant Biotechnologies in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.